An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus

被引:17
作者
Kim, Do-Hyoung [1 ]
Ni, Yi [2 ]
Lee, Si-Hyung [1 ]
Urban, Stephan [2 ]
Han, Kyou-Hoon [1 ]
机构
[1] Korea Res Inst Biosci & Biotechnol, Div Mol Therapeut, Mol Canc Res Ctr, Taejon 305806, South Korea
[2] Heidelberg Univ, Dept Mol Virol, Otto Meyerhof Zentrum, D-69120 Heidelberg, Germany
关键词
hepatitis B virus (HBV); intrinsically unstructured protein (IUP); lipo-peptides; local pre-structured motif; nuclear magnetic resonance (Nmr); preS1;
D O I
10.5483/BMBRep.2008.41.9.640
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The preS1 surface protein of the hepatitis B virus (HBV) is a key factor involved in initial viral entry into hepatocytes. It has been long postulated that an anti-HBV effect should be achievable using peptide fragments of the preS1. Recent reports demonstrated that several preS1-derived lipo-peptides in genotype D HBV exhibit nano to picomolar inhibitory activity against HBV infection. In this study, an acylated analog of a preS1 fragment, a 21-residue lipo-peptide (named 7524 BVS7) with a sequence of palmitoyl-GMGTNLSVPNPLGFFPDHQLDC-NH2, from genotype C HBV was produced base upon a previous structural study and was shown potently inhibits HBV infection with an IC50 of approximate to 20 nM.
引用
收藏
页码:640 / 644
页数:5
相关论文
共 37 条
[1]   Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition [J].
Barrera, A ;
Guerra, B ;
Notvall, L ;
Lanford, RE .
JOURNAL OF VIROLOGY, 2005, 79 (15) :9786-9798
[2]   Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27Kip1 [J].
Bienkiewicz, EA ;
Adkins, JN ;
Lumb, KJ .
BIOCHEMISTRY, 2002, 41 (03) :752-759
[3]  
BLUMBERG BS, 1989, CANCER DETECT PREV, V14, P195
[4]   Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A [J].
Bochkareva, E ;
Kaustov, L ;
Ayed, A ;
Yi, GS ;
Lu, Y ;
Pineda-Lucena, A ;
Liao, JCC ;
Okorokov, AL ;
Milner, J ;
Arrowsmith, CH ;
Bochkarev, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15412-15417
[5]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236
[6]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[7]   Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus [J].
Chi, Seung-Wook ;
Kim, Do-Hyoung ;
Lee, Si-Hyung ;
Chang, Iksoo ;
Han, Kyou-Hoon .
PROTEIN SCIENCE, 2007, 16 (10) :2108-2117
[8]   Structural details on mdm2-p53 interaction [J].
Chi, SW ;
Lee, SH ;
Kim, DH ;
Ahn, MJ ;
Kim, JS ;
Woo, JY ;
Torizawa, T ;
Kainosho, M ;
Han, KH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (46) :38795-38802
[9]   Antiviral agents active against influenza A viruses [J].
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :1015-1025
[10]   Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells [J].
De Falco, S ;
Ruvoletto, MG ;
Verdoliva, A ;
Ruvo, M ;
Raucci, A ;
Marino, M ;
Senatore, S ;
Cassani, G ;
Alberti, A ;
Pontisso, P ;
Fassina, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) :36613-36623